Related Experiment Video
Updated: May 7, 2026
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Novel treatments for melanoma brain metastases
Rajappa S Kenchappa1, Nam Tran, Nikhil G Rao
1Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA. Peter.Forsyth@Moffitt.org.
Background:
The development of brain metastases is common in patients with melanoma and is associated with a poor prognosis. Treating patients with melanoma brain metastases (MBMs) is a major therapeutic challenge. Standard approaches with conventional chemotherapy are disappointing, while surgery and radiotherapy have improved outcomes.
Methods:
In this article, we discuss the biology of MBMs, briefly outline current treatment approaches, and emphasize novel and emerging therapies for MBMs.
Results:
The mechanisms that underlie the metastases of melanoma to the brain are unknown; therefore, it is necessary to identify pathways to target MBMs. Most patients with MBMs have short survival times. Recent use of immune-based and targeted therapies has changed the natural history of metastatic melanoma and may be effective for the treatment of patients with MBMs.
Conclusions:
Developing a better understanding of the factors responsible for MBMs will lead to improved management of this disease. In addition, determining the optimal treatments for MBMs and how they can be optimized or combined with other therapies, along with appropriate patient selection, are challenges for the management of this disease.
Insights
Melanoma brain metastases (MBMs) present a significant challenge. Novel immune-based and targeted therapies show promise for improving outcomes in patients with MBMs.
Area of Science:
- Oncology
- Neuro-oncology
- Melanoma Research
Background:
- Melanoma brain metastases (MBMs) are common and linked to poor prognosis.
- Conventional chemotherapy is largely ineffective for MBMs.
- Surgery and radiotherapy offer some improvement in outcomes.
Purpose of the Study:
- To discuss the biology of MBMs.
- To outline current treatment approaches for MBMs.
- To emphasize novel and emerging therapies for MBMs.
Main Methods:
- Review of current literature on melanoma brain metastases.
- Analysis of biological mechanisms underlying MBMs.
- Evaluation of emerging therapeutic strategies.
Main Results:
- Mechanisms of melanoma metastasis to the brain remain largely unknown.
- Most patients with MBMs experience short survival times.
- Immune-based and targeted therapies are altering the natural history of metastatic melanoma and show potential for MBM treatment.
Conclusions:
- Understanding MBM development is crucial for improved management.
- Optimizing and combining MBM treatments, alongside patient selection, are key challenges.
- Further research into MBMs is essential for advancing patient care.
Related Concept Videos
02:56Treatment Resistant Cancers
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy